HoloLens 2 has a better field of view and more natural interaction to allow users to tap objects Tech giant Microsoft recently introduced the new version of HoloLens, its mixed reality technology headset, at the Mobile World Congress 2019 in Barcelona. The product would reportedly …
The new Calibry 3D scanner is the first of Thor3D’s products to incorporate a patent-pending camera The scanner has been priced at €4,990 (USD 5,790 or RMB 39,990) Thor3D, a leading provider of 3D imaging and complex data processing equipment, has reportedly announced the launch …
KeHE Distributors LLC (KeHE) has recently announced that the company has renewed its supply agreement for organic, natural and specialty products with the American grocery giant Albertsons Companies, as its primary distribution partner. President and Chief Executive Officer of KeHE Distributors, Brandon Barnholt, said in …
Honda has apparently become the latest organization making plans for leaving Britain, as the nation prepares to exit the European Union and global forces are looking to reshape the car industry. The company recently confirmed that it would shut its factory in Swindon, England, that …
Pöyry, which provides consulting services on CFD, has reportedly launched a new digital service, Advanced Modelling and Simulation (AMS) for building new value for its clients, assisting them in making better informed decisions at an early stage, optimizing OPEX costs, reducing risks along with maximizing …
Axiata Group, which is the largest stakeholder in Singapore telco M1, has reportedly accepted an offer for its interest in the company from M1’s investors, Singapore Press Holdings (SPH) and Keppel Corp (KCL) after several months of ongoing negotiations. Apparently, acceptance of the bid would …
Reports suggest that social network giant Facebook could be facing a record fine with regards to the privacy lapses it has recently been accused of. The company is said to be in negotiations for an agreement with the Federal Trade Commission (FTC) which may lead …
Achilles Therapeutics, a biopharmaceutical company committed to the development of personalized cancer immunotherapies, has reportedly attained the approval of its Clinical Trial Application to perform a Phase I/II study on patients with melanoma by the UK Medicines and Healthcare products Regulatory Agency. As per trusted …
